Ambrisentan shortage: patients with pulmonary hypertension struggle

Supply shortages of ambrisentan, a vital drug for pulmonary hypertension, have persisted for months.

Published 7sem1 sourceNotableupdated 4j

≈ 16sSpeed

The fact

Viatris laboratory limits distributions to hospital pharmacies and retail outlets.

Health authorities recommend therapeutic alternatives, but access remains unequal.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on June 25, 2026